AMSilk Secures Additional €25M, Totalling €54M for Bioproduced Silk Protein Materials
AMSilk GmbH, a German provider of biofabricated silk protein materials, has announced a successful €25 million raise in its extended Series C round, bringing the total to €54 million. The additional funding was led by previous investor ATHOS (AT Newtec), with contributions from Novo Holdings, Cargill, and MIG Capital. The Munich-based biotech leverages its technology platform, based on vegan silk proteins, to create 100% fully biodegradable and microplastic-free silk materials that will contribute to building a zero-waste society. They can be used in multiple applications, from powders, hydrogels, textile fibres, aerospace applications, and coatings for the medical, automotive, and textile industries. Expanding commercial operations “We are delighted to have closed this successful financing round which validates our technology and underpins our ongoing development as we …